Literature DB >> 6770869

Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates.

S A Barker, J A Monti, S T Christian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6770869     DOI： 10.1016/0006-2952(80)90169-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  11 in total

Review 1.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 2.  New Paradigms of Old Psychedelics in Schizophrenia.

Authors:  Danish Mahmood; Sattam K Alenezi; Md Jamir Anwar; Faizul Azam; Kamal A Qureshi; Mariusz Jaremko
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-23

Review 3.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

Review 4.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

5.  CSF and plasma pharmacokinetics of pethidine and norpethidine in man after epidural and intrathecal administration of pethidine.

Authors:  G Nordberg; V Hansdottir; U Bondesson; L O Boréus; T Mellstrand; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice.

Authors:  A Morinan; J G Collier
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Pharmacokinetics of tetrahydronorharmane (tetrahydro-beta-carboline) in rats.

Authors:  B Greiner; C Fähndrich; S Strauss; H Rommelspacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000

8.  In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine.

Authors:  K Yanai; T Ido; K Ishiwata; J Hatazawa; T Takahashi; R Iwata; T Matsuzawa
Journal:  Eur J Nucl Med       Date:  1986

9.  A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience.

Authors:  Andrew R Gallimore; Rick J Strassman
Journal:  Front Pharmacol       Date:  2016-07-14       Impact factor: 5.810

Review 10.  N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.

Authors:  Steven A Barker
Journal:  Front Neurosci       Date:  2018-08-06       Impact factor: 4.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.